Dermatology Drug Development Summit Europe

” With granular insight into innovative therapeutic approaches and solutions to existing challenges, the Dermatology Drug Development Summit Europe will bring together leading European-based pharma, biotech and industry stakeholders to discuss how to transform and enhance the success of dermatology drug development activities. ”

Conference with Jean-François Ginglinger:

TEM1657 – A Novel Small Molecule Approach Targeting Psoriasis

• Describing TEM1657, a novel small molecule asset showing unrivalled efficacy to reduce psoriasis symptoms in IMQ animal model
• Analysing TEM1657’s MOA – regulation of a key player in the IL-17 signalling pathway in keratinocytes
• Exploring next steps into clinical trials

> More informations